NextCure, Inc.NXTCNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank88
3Y CAGR+70.3%
5Y CAGR+2.5%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
+70.3%/yr
Annual compound
5Y CAGR
+2.5%/yr
Recent acceleration
Percentile
P88
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
3 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.15 | +250.6% |
| 2024 | 0.33 | +18.7% |
| 2023 | 0.28 | +18.8% |
| 2022 | 0.23 | -67.1% |
| 2021 | 0.71 | -30.5% |
| 2020 | 1.02 | -62.8% |
| 2019 | 2.75 | +128.6% |
| 2018 | -9.63 | +48.0% |
| 2017 | -18.52 | - |